Revolution Medicines Inc

RVMD

Company Profile

  • Business description

    Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

  • Contact

    700 Saginaw Drive
    Redwood CityCA94063
    USA

    T: +1 650 481-6801

    https://www.revmed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    700

Stocks News & Analysis

stocks

3 Warren Buffett stocks to avoid today

These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
stocks

Should you invest in small caps?

With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio. 
stocks

Strong second half anticipated for ASX mining play

A more focused business model should benefit the company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,079.2017.700.20%
CAC 407,843.7648.340.62%
DAX 4023,624.0889.250.38%
Dow JONES (US)45,947.32173.96-0.38%
FTSE 1009,261.3947.410.51%
HKSE26,128.20356.48-1.35%
NASDAQ22,384.70113.16-0.50%
Nikkei 22545,354.99399.94-0.87%
NZX 50 Index13,111.7342.06-0.32%
S&P 5006,604.7233.25-0.50%
S&P/ASX 2008,787.7013.200.15%
SSE Composite Index3,828.1125.20-0.65%

Market Movers